Thrombosis risk during pregnancy after history of cerebral venous thrombosis;Risque thrombotique des grossesses après un épisode de thrombose veineuse cérébrale

Revue de Medecine Interne

Volumn 36, Issue 1, 2015, Pages 10-14

  Pourrat, O ^a   Neau, J P ^a   Pouget Abadie, J F ^b   Pierre, F ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b Centre hospitalier Georges Renon   (France)

Author keywords

Antithrombotics; Cerebral venous thrombosis; High risk pregnancy; Stroke; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; ANTICOAGULANTS; ASPIRIN;

ARTICLE; CASE STUDY; CEREBRAL SINUS THROMBOSIS; CLINICAL ARTICLE; FEMALE; HUMAN; LUNG EMBOLISM; MEDICAL HISTORY; PREGNANCY DISORDER; PROGNOSIS; PUERPERIUM; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; ADULT; CHEMOPREVENTION; COMPLICATION; FAMILY HEALTH; HUMANS; INTRACRANIAL THROMBOSIS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS AND NUMERICAL DATA; THROMBOSIS; YOUNG ADULT;

ADULT; ANTICOAGULANTS; ASPIRIN; CHEMOPREVENTION; FAMILY HEALTH; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; YOUNG ADULT;

EID: 84922058850     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2013.08.002     Document Type: Article

References (31)

1. Dentali F., Gianni M., Crowther M.A., Ageno W. Natural history of cerebral vein thrombosis: a systematic review. Blood 2006, 108:1129-1134.
2. Lanska D.J., Kryscio R.J. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000, 31:1274-1282.
3. Preter M., Tzourio C., Ameri A., Bousser M.G. Long-term prognosis in cerebral venous thrombosis: follow-up of 77 patients. Stroke 1996, 27:243-246.
4. Ferro J.M., Canhão P., Stam J., Bousser M.G., Barinagarrementeria F., ISCVT Investigators Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004, 35:664-670.
5. Miranda B., Ferro J.M., Canhão P., Stam J., Bousser M.G., Barinagarrementeria F., et al. Venous thromboembolic events after cerebral vein thrombosis. Stroke 2010, 41:1901-1906.
6. Maqueda V.M., Thijs V. Risk of thromboembolism after cerebral venous thrombosis. Eur J Neurol 2006, 13:302-305.
7. Martinelli I., Bucciarelli P., Passamonti S.M., Battaglioli T., Previtali E., Mannucci P.M. Long-term evaluation of the risk of recurrence after cerebral sinus venous thrombosis. Circulation 2010, 121:2740-2746.
8. Dentali F., Poli D., Scoditti U., Di Minno M.N., De Stefano V., Siragusa S., et al. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost 2012, 10:1297-1302.
9. Tufano A., Guida A., Coppola A., Nardo A., Di Capua M., Quintavalle G., et al. Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis. Blood Transfus 2013, 1-6. [Epub ahead of print]. 10.2450/2013.0196-12.
10. Saposnik G., Barinagarrementeria F., Brown R.D., Bushnell C.D., Cucchiara B., Cushman M., et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:1158-1192.
11. Lamy C., Hamon J.B., Coste J., Mas J.L. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy. Neurology 2000, 55:239-274.
12. Mehraein S., Ortwein H., Busch M., Weih M., Einhäupl K., Masuhr F. Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry 2003, 74:814-816.
13. Bousser M.G., Crassard I. Cerebral venous thrombosis, pregnancy and oral contraceptives. Thromb Res 2012, 130(Suppl.1):S19-S22.
14. Bombeli T., Raddatz-Mueller P., Fehr J. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women. Am J Obstet Gynecol 2001, 184:382-389.
15. ANAES, Conférence de consensus «Thrombophilie et grossesse» Prévention des risques thrombotiques maternels et placentaires. Recommandations du jury (version courte). Ann Med Interne 2003, 154:422-430.
16. SFAR, Prévention de la maladie veineuse thromboembolique postopératoire et obstétricale. Recommandations pour la Pratique Clinique (version courte). 2005: . http://www.sfar.org/prevention-de-la-maladie-thromboembolique-veineuse-perioperatoire-et-obstetricale-rpc-2005.
17. Bates S.M., Greer I.A., Pabinger I., Sofaer S., Hirsh J., American College of Chest Physicians Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(Suppl.6):S844-S886.
18. Sacco R.L., Adams R., Albers G., Alberts M.J., Benavente O., Furie K., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006, 113:e409-e449.
19. Romualdi E., Dentali F., Rancan E., Squizzato A., Steidl L., Middeldorp S., et al. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemost 2013, 11:270-281.
20. Becattini C., Agnelli G., Schenone A., Eichinger S., Bucherini E., Silingardi M., et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012, 366:1959-1967.
21. Ferrières C., Conard J., Blacher J. Aspirine et prévention de la maladie veineuse thromboembolique: la suite d'une belle histoire. J Mal Vasc 2013, 38:4-5.
22. CLASP Collaborative group Low dose aspirin in pregnancy and early childhood development: follow-up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group. Br J Obstet Gynaecol 1995, 102:861-868.
23. CLASP Collaborative group CLASP: a randomised trial of low dose aspirin for the prevention and treatment of pre-eclampsia among 9364pregnant women. CLASP (Collaborative Low dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994, 343:619-629.
24. Kapessidou Y., Vokaer M., Laureys M., Bier J.C., Boogaerts J.G. Case report: cerebral vein thrombosis after subarachnoid analgesia for labour. Can J Anaesth 2006, 53:1015-1019.
25. Wittmann M., Dewald D., Urbach H., Gast A.S., Linnebank M., Buamgarten G., et al. Sinus venous thrombosis: a differential diagnosis of postpartum headache. Arch Gynecol Obstet 2012, 285:93-97.
26. Canhão P., Abreu L.F., Ferro J.M., Stam J., Bousser M.G., Barinagarrementeria F., et al. Safety of lumbar puncture in patients with cerebral venous thrombosis. Eur J Neurol 2013, 20:1075-1080.
27. Lévesque H., Hanslik T. Contraception œstroprogestative et risque thrombotique: des faits cliniques aux conséquences médiatiques. Rev Med Interne 2013, 34:453-455.
28. Conard J., Plu-Bureau G., Bahi N., Horellou M.H., Pelissier C., Thalabard J.C. Progestogen-only contraception in women at high risk of venous thromboembolism. Contraception 2004, 70:437-441.
29. Madelenat P., Koskas M., Groupe de réflexion sur la contraception progestative Mise au point sur la contraception progestative. J Gynecol Obstet Biol Reprod (Paris) 2008, 37:637-660.
30. Gourdy P., Bachelot A., Catteau-Jonard S., Chabbert-Buffet N., Christin-Maître S., Conard J., et al. Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology. Ann Endocrinol (Paris) 2012, 73:469-487.
31. Lidegaard Ø., Nielsen L.H., Skovlund C.W., Skjeldestad F.E., Løkkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-2009. BMJ 2011, 343:d6423.